Previously doing business in Illinois, in 2006 the firm relocated to California. BioTechPlex provides enabling products for the discovery and development of devices and supplies for respiratory and cardiovasuclar drug discovery, development and aerosol delivery of biologics (proteins, liposomes, nucleotides, siRNA etc) as well as toxicology and safety pharmocology. BioTechPlex's technologies address unmet needs for cell-based and small animal-based assays for target screening, validation and safety pharmacology and patient monitoring and respiratory aerosol drug delivery. With a strong emphasis on collaborative endeavors, BioTechPlex's diverse set of core competencies gives the company the unique ability to develop the following: * Intelligent, cell-based high-throughput screening systems for drug discovery and scientific research * Advanced fluorescence based enabling technologies and optoelectronic systems * Integrated computer hardware and software application platforms based on advanced information technology and biomedical signal processing techniques * Cell culture models based on advanced molecular and cellular engineering * Whole animal models for cardiopulmonary physiology research, pharmacology and drug development * SUPRAER. High Dose Rate Aerosol Drug Delivery * Asthma Drug Targets
